Hypertension Refills

TeleDirectMD operates as a cash-pay practice in Vermont. Your $79 visit fee is paid at booking. Prescription costs are filled separately at your pharmacy and may be covered by your pharmacy benefit. HSA and FSA cards are accepted. There is no insurance billing in Vermont — straightforward, transparent pricing.

Yes. 18 V.S.A. Chapter 219 permits licensed physicians to prescribe appropriate medications via synchronous video telehealth without a prior in-person visit. TeleDirectMD\'s Vermont-licensed board-certified Family Medicine physician reviews your home blood pressure log, current medications, and most recent lab values (potassium, creatinine, eGFR for ACE inhibitors or ARBs) before authorizing refills for stable established hypertension. Self pay is $79.

TeleDirectMD can refill established antihypertensive medications including ACE inhibitors (lisinopril, ramipril), ARBs (losartan, valsartan, olmesartan), dihydropyridine calcium channel blockers (amlodipine), thiazide-type diuretics (chlorthalidone, HCTZ), and cardioselective beta-blockers (metoprolol succinate) for appropriate indications. Medication selection follows ACC/AHA 2017 and 2024 update guidelines.

Roughly 1 in 3 Vermont adults have hypertension, in line with national rural prevalence (CDC). Because Vermont is the second-oldest state by median age and 64.8% of residents live in rural areas — the second-highest rural share in the U.S. — hypertension is one of the state\'s most common chronic conditions, and rural residents face longer travel times to in-person care.

The ACC/AHA 2017 guideline recommends a blood pressure target of less than 130/80 mmHg for most adults with confirmed hypertension, particularly those with established cardiovascular disease or a 10-year ASCVD risk of ≥10%. The 2024 ACC hypertension update reinforces this target and identifies chlorthalidone as the preferred thiazide diuretic over hydrochlorothiazide due to superior 24-hour coverage. The physician individualizes targets for frail elderly patients or those with significant comorbidities.

The 2024 ACC hypertension guideline update reinforces chlorthalidone as the preferred thiazide-type diuretic over hydrochlorothiazide (HCTZ). Chlorthalidone has a longer half-life (50–60 hours vs. 8–15 hours for HCTZ), providing better 24-hour blood pressure control and superior outcomes in the ALLHAT trial. Chlorthalidone is available as generic at approximately $10–$25 per month with a GoodRx coupon at Vermont pharmacies.

Before a hypertension refill visit, the physician reviews your home blood pressure log (5–7 readings recommended), most recent potassium and creatinine/eGFR if you are on an ACE inhibitor or ARB, and any recent complete metabolic panel. Labs should be current within 12 months for stable patients. If labs are overdue, the physician will recommend repeat testing as a condition of continued refills. Labs are available at Quest Diagnostics and LabCorp draw sites, hospital outpatient labs, and Vermont federally qualified health centers (FQHCs) across the state.

Hypertension requires urgent in-person evaluation for: blood pressure readings ≥180/120 mmHg (hypertensive urgency/emergency), new severe headache with high BP, chest pain, shortness of breath, visual changes, or neurological symptoms with elevated BP (possible hypertensive emergency). New hypertension diagnoses with unknown secondary cause (e.g., possible renal artery stenosis, primary aldosteronism) also benefit from in-person workup. TeleDirectMD is appropriate for stable established hypertension.

Generic antihypertensive medications are among the most affordable prescriptions with GoodRx coupons at Vermont pharmacies. Lisinopril 10 mg per month: approximately $4–$12. Amlodipine 5 mg: approximately $4–$10. Losartan 50 mg: approximately $8–$20. Chlorthalidone 25 mg: approximately $10–$25. Metoprolol succinate 50 mg: approximately $10–$30. These are GoodRx coupon prices as of May 2026 — actual prices vary by pharmacy and dose.

For newly elevated blood pressure readings without a prior hypertension diagnosis, TeleDirectMD can perform an initial assessment, review home readings, and discuss lifestyle modifications. However, Stage 2 hypertension (≥140/90) without a prior workup may benefit from in-person evaluation to rule out secondary causes (renal, endocrine), review 10-year ASCVD risk, and obtain baseline labs. The physician will guide you on whether an in-person visit is needed before starting antihypertensive therapy.